Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy (RT) in patients with stage III non-small-cell lung cancer (NSCLC)

Ball, D, Rischin, D, Burmeister, B, Mitchell, P, Boyer, M, MacManus, M and Walpole, E (2004). Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy (RT) in patients with stage III non-small-cell lung cancer (NSCLC). In: Lung Cancer. 9th Central European Lung Cancer Conference, Gdansk Poland, (S52-S53). Sep 23-25, 2004.

Author Ball, D
Rischin, D
Burmeister, B
Mitchell, P
Boyer, M
MacManus, M
Walpole, E
Title of paper Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy (RT) in patients with stage III non-small-cell lung cancer (NSCLC)
Conference name 9th Central European Lung Cancer Conference
Conference location Gdansk Poland
Conference dates Sep 23-25, 2004
Proceedings title Lung Cancer   Check publisher's open access policy
Journal name Lung Cancer   Check publisher's open access policy
Publication Year 2004
Sub-type Published abstract
ISSN 0169-5002
Volume 45
Start page S52
End page S53
Total pages 2
Language eng
Q-Index Code EX

Document type: Conference Paper
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Wed, 03 Jul 2013, 16:20:59 EST by System User